Home LiteratureArticle Details
PMID: 6601061 Published · ppublish English Journal Article

Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates.

Infection and immunity ·Vol. 40 ·No. 1 ·1983-04-00 ·Pages 245-56

Chu C, Schneerson R, Robbins JB, Rastogi SC

Abstract

Conjugates were prepared by carbodiimide-mediated coupling of adipic acid hydrazide derivatives of Haemophilus influenzae type b (Hib), Escherichia coli K100, and pneumococcal 6A (Pn6A) polysaccharides with tetanus toxoid (TT), as an example of a "useful" carrier, and horseshoe crab hemocyanin (HCH), as an example of a "nonsense" carrier. These conjugates were injected into NIH mice, and their serum antibody responses to the polysaccharides and proteins were characterized. As originally reported, Hib conjugates increased the immunogenicity of the capsular polysaccharide and elicited greater than the estimated protective levels of anti-Hib antibodies in most recipients after one injection and in all after the third injection (Schneerson et al., J. Exp. Med. 152:361-376, 1980). Both Hib conjugates induced similar anti-Hib responses. The K100-HCH conjugate was more immunogenic than the K100-TT conjugate and elicited anti-Hib responses similar to the Hib conjugates after the third injection. Simultaneous injection of the K100 and the Hib conjugates did not enhance the anti-Hib response. The Pn6A-TT conjugate induced low levels of anti-Hib antibodies; when injected simultaneously with the Hib conjugates, the anti-Hib response was enhanced, as all mice responded after the first injection and with higher levels of anti-Hib than observed with the Hib conjugates alone (P < 0.05). The Pn6A conjugates were not as immunogenic as the Hib conjugates. Pn6A-TT was more effective than was Pn6A-HCH; it elicited anti-Pn6A (>100 ng of antibody nitrogen per ml) in 6 of 10 mice after the third injection. The addition of the Hib-HCH conjugate to the Pn6A-TT conjugate increased the anti-Pn6A response with a higher geometric mean antibody titer, and 9 of 10 mice responded after the third injection. A preparation of diphtheria toxoid, TT, and pertussis vaccine increased the anti-Hib antibody levels after the first injection only in mice receiving Hib-TT, but not in mice receiving Hib-HCH, suggesting that additional carrier protein (TT) enhanced the anti-polysaccharide response. Simultaneous injection of Hib and Pn6A conjugates with the same or different carriers resulted in an enhanced serum antibody response to each polysaccharide. The anti-tetanus toxin response reached protective levels (>0.01 U/ml) in most mice after the first injection and in all mice after the second and third injections of TT conjugates. A progressive increase in the anti-HCH response with each additional injection was noted in animals receiving HCH conjugates. Animals receiving the diphtheria toxoid-TT-pertussis vaccine preparation responded with a greater increase in anti-carrier antibody than those receiving the conjugates alone. This method of synthesis provided conjugates capable of inducing protective levels of antibodies to both the polysaccharides and carrier proteins.

MeSH Terms
Animals Antibodies, Bacterial/biosynthesis Carrier Proteins/administration & dosage,immunology Cross Reactions Diphtheria Toxoid/administration & dosage,immunology Female Haemophilus influenzae/immunology Hemocyanins/administration & dosage,immunology Meningitis, Haemophilus/immunology Mice Mice, Inbred Strains Pertussis Vaccine/administration & dosage,immunology Polysaccharides, Bacterial/administration & dosage,immunology Streptococcus pneumoniae/immunology Tetanus Toxoid/administration & dosage,immunology
Chemicals
Antibodies, Bacterial Carrier Proteins Diphtheria Toxoid Pertussis Vaccine Polysaccharides, Bacterial Tetanus Toxoid Hemocyanins
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Chu C
Schneerson R
Robbins J B
Rastogi S C
References (49)
49 references, click to expand
  1. Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease.
    N Engl J Med. 1978 Aug 31;299(9):442-8 PMID: 28483
  2. Semi-synthetic vaccines composed of capsular polysaccharides of pathogenic bacteria covalently bound to proteins for the prevention of invasive diseases.
    Prog Allergy. 1983;33:144-58 PMID: 6600843
  3. Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b.
    J Clin Invest. 1972 Jan;51(1):39-44 PMID: 4536615
  4. The effect of Bordetella pertussis on the antibody response in mice to type III pneumococcal polysaccharide.
    J Immunol. 1976 Apr;116(4):989-93 PMID: 3610
  5. Age-related response to two Haemophilus influenzae type b vaccines.
    J Pediatr. 1982 Feb;100(2):197-201 PMID: 7035637
  6. Modification of antibody response to type III pneumopolysaccharide by route of injection of pertussis vaccine.
    Infect Immun. 1979 Mar;23(3):675-80 PMID: 37163
  7. THE ACTION OF TYPE-SPECIFIC HEMOPHILUS INFLUENZAE ANTISERUM.
    J Exp Med. 1933 Nov 30;58(6):683-706 PMID: 19870224
  8. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.
    Pediatrics. 1977 Nov;60(5):730-7 PMID: 335348
  9. The Protective or Curative Element in Type B H. influenzae Rabbit Serum.
    Yale J Biol Med. 1944 May;16(5):425-34 PMID: 21434159
  10. The bacteriology of pneumococcal otitis media.
    Johns Hopkins Med J. 1977 Sep;141(3):104-11 PMID: 894852
  11. Comparative immunogenicity of group 6 pneumococcal type 6A(6) and type 6B(26) capsular polysaccharides.
    Infect Immun. 1979 Dec;26(3):1116-22 PMID: 43290
  12. Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b.
    Pediatrics. 1973 Nov;52(5):637-44 PMID: 4542777
  13. Structural studies of the capsular antigen from Streptococcus pneumoniae type 26.
    Carbohydr Res. 1979 Aug;73:175-82 PMID: 38908
  14. Comparison of the induction of immunoglobulin M and G antibodies in mice with purified pneumococcal type 3 and meningococcal group C polysaccharides and their protein conjugates.
    Infect Immun. 1982 Jul;37(1):15-22 PMID: 6809623
  15. An Escherichia coli antigen cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b: occurrence among known serotypes, and immunochemical and biologic properties of E. coli antisera toward H. influenzae type b.
    J Immunol. 1972 Jun;108(6):1551-62 PMID: 4624175
  16. A study of the pneumococcal vaccine in prevention of clinically acute atttacks of recurrent otitis media.
    Rev Infect Dis. 1981 Mar-Apr;3 Suppl:S124-32 PMID: 6974386
  17. Antibody responses to a combination vaccine against Haemophilus influenzae type b, diphtheria, pertussis, and tetanus.
    Bull World Health Organ. 1975;52(1):87-90 PMID: 174825
  18. Immunization against neonatal tetanus in New Guinea. 3. The toxin-neutralization test and the response of guinea-pigs to the toxoids as used in the immunization schedules in New Guinea.
    Bull World Health Organ. 1970;43(3):453-9 PMID: 5312999
  19. Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.
    J Exp Med. 1980 Aug 1;152(2):361-76 PMID: 6967514
  20. Accelerated and prolongated multiplication of antibody-forming spleen cells by Bordetella pertussis in mice immunized with sheep red blood cells.
    Experientia. 1967 Jul 15;23(7):591-2 PMID: 4293664
  21. Cross-reactivity with Escherichia coli K100 in the human serum anticapsular antibody response to Haemophilus influenzae type B.
    J Immunol. 1982 Mar;128(3):1267-70 PMID: 7035561
  22. Antibody response of infants to cell surface-exposed outer membrane proteins of Haemophilus influenzae type b after systemic Haemophilus disease.
    Infect Immun. 1982 Jul;37(1):82-8 PMID: 6980838
  23. A method for the quantitative modification and estimation of carboxylic acid groups in proteins.
    J Biol Chem. 1967 May 25;242(10):2447-53 PMID: 6026234
  24. Inhibitory effect of K-76 monocarboxylic acid, an anticomplementary agent, on the C3b inactivator system.
    J Immunol. 1981 Jul;127(1):104-8 PMID: 7240739
  25. A method for producing specific antisera with small doses of immunogen.
    J Clin Endocrinol Metab. 1971 Dec;33(6):988-91 PMID: 5316354
  26. Capsular polymer of Haemophilus influenzae, type b. I. Structural characterization of the capsular polymer of strain Eagan.
    J Biol Chem. 1975 Jul 10;250(13):4926-30 PMID: 1080151
  27. The modulating effect of cholera enterotoxin on the immune response.
    J Immunol. 1974 Sep;113(3):729-39 PMID: 4370486
  28. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine.
    N Engl J Med. 1980 Sep 4;303(10):549-52 PMID: 6995835
  29. Human antibody response to individual outer membrane proteins of Haemophilus influenzae type b.
    Infect Immun. 1982 Sep;37(3):1032-6 PMID: 6982229
  30. Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies.
    Pediatr Res. 1973 Mar;7(3):103-10 PMID: 4120458
  31. Safety and immunogenicity of a new Haemophilus influenzae type b vaccine in infants under one year of age.
    Lancet. 1981 Oct 3;2(8249):705-9 PMID: 6116855
  32. Immunoglobulin E-suppressing and immunoglobulin G-enhancing tetanus toxoid prepared by conjugation with pullulan.
    Infect Immun. 1982 Jun;36(3):971-6 PMID: 7095857
  33. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
  34. Interim report of a controlled field trial of immunization with capsular polysaccharides of Haemophilus influenzae type b and group C Neisseria meningitidis in Mecklenburg county, North Carolina (March 1974-March 1976).
    J Infect Dis. 1977 Aug;136 Suppl:S51-6 PMID: 408433
  35. Effect of combinations of inbred strain, antigen, and antigen dose on immune responsiveness and reagin production in the mouse. A potential mouse model for immune aspects of human atopic allergy.
    Int Arch Allergy Appl Immunol. 1970;39(2-3):156-71 PMID: 4097264
  36. Clinical studies of pneumococcal vaccines in infants. I. Reactogenicity and immunogenicity of two polyvalent polysaccharide vaccines.
    Rev Infect Dis. 1981 Mar-Apr;3 Suppl:S97-107 PMID: 7280450
  37. Assessment of the antibody response to pneumococcal vaccine in high-risk populations.
    Rev Infect Dis. 1981 Mar-Apr;3 Suppl:S184-97 PMID: 7025158
  38. CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : I. THE SYNTHESIS OFp-AMINOPHENOL beta-GLUCOSIDE, p-AMINOPHENOL beta-GALACTOSIDE, AND THEIR COUPLING WITH SERUM GLOBULIN.
    J Exp Med. 1929 Sep 30;50(4):521-31 PMID: 19869644
  39. Induction of serum Haemophilus influenzae type B capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5.
    N Engl J Med. 1975 May 22;292(21):1093-6 PMID: 48191
  40. Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants.
    Proc Soc Exp Biol Med. 1978 Jan;157(1):148-54 PMID: 23549
  41. Immunity to disease caused by Hemophilus influenzae type b. II. Specificity and some biologic characteristics of "natural," infection-acquired, and immunization-induced antibodies to the capsular polysaccharide of Hemophilus influenzae type b.
    J Immunol. 1971 Oct;107(4):1081-9 PMID: 5315273
  42. Formation of IgE-binding factors by rat T lymphocytes. II. Mechanisms of selective formation of IgE-potentiating factors by treatment with Bordetella pertussis vaccine.
    J Immunol. 1981 Nov;127(5):1804-10 PMID: 6975297
  43. Standardization and control of meningococcal vaccines, group A and group C polysaccharides.
    J Biol Stand. 1977;5(3):197-215 PMID: 408354
  44. Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.
    J Immunol. 1972 Jul;109(1):129-35 PMID: 4113792
  45. A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Method for the radioimmunoassay of anticapsular antibodies and comparison with other techniques.
    J Immunol Methods. 1980;33(2):133-44 PMID: 6154745
  46. Subunit association and heterogeneity of Limulus polyphemus hemocyanin.
    Biochemistry. 1978 Apr 18;17(8):1448-55 PMID: 646993
  47. VARIATION AND TYPE SPECIFICITY IN THE BACTERIAL SPECIES HEMOPHILUS INFLUENZAE.
    J Exp Med. 1931 Mar 31;53(4):471-92 PMID: 19869858
  48. Haemophilus influenzae type B polysaccharide-protein conjugates: model for a new generation of capsular polysaccharide vaccines.
    Prog Clin Biol Res. 1980;47:77-94 PMID: 6970933
  49. The derivatization of cross-linked polyacrylamide beads. Controlled introduction of functional groups for the preparation of special-purpose, biochemical adsorbents.
    Biochemistry. 1969 Oct;8(10):4074-82 PMID: 5388146
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1983-04-00
Pages
245-56
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC264842
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]